- Home
- BSM vs ARWR Comparison
BSM vs ARWR Comparison
Compare BSM & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSM
- ARWR
- Stock Information
- Founded
- BSM 1876
- ARWR 2003
- Country
- BSM United States
- ARWR United States
- Employees
- BSM N/A
- ARWR N/A
- Industry
- BSM Oil & Gas Production
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- BSM Energy
- ARWR Health Care
- Exchange
- BSM Nasdaq
- ARWR Nasdaq
- Market Cap
- BSM 2.6B
- ARWR 2.5B
- IPO Year
- BSM 2015
- ARWR 1993
- Fundamental
- Price
- BSM $11.97
- ARWR $29.08
- Analyst Decision
- BSM Hold
- ARWR Strong Buy
- Analyst Count
- BSM 1
- ARWR 9
- Target Price
- BSM $13.00
- ARWR $47.75
- AVG Volume (30 Days)
- BSM 503.2K
- ARWR 3.1M
- Earning Date
- BSM 11-03-2025
- ARWR 08-07-2025
- Dividend Yield
- BSM 10.03%
- ARWR N/A
- EPS Growth
- BSM N/A
- ARWR N/A
- EPS
- BSM 1.16
- ARWR N/A
- Revenue
- BSM $413,675,000.00
- ARWR $572,976,000.00
- Revenue This Year
- BSM $10.58
- ARWR $22,306.37
- Revenue Next Year
- BSM $14.68
- ARWR N/A
- P/E Ratio
- BSM $10.28
- ARWR N/A
- Revenue Growth
- BSM N/A
- ARWR 2816.20
- 52 Week Low
- BSM $11.90
- ARWR $9.57
- 52 Week High
- BSM $15.66
- ARWR $29.34
- Technical
- Relative Strength Index (RSI)
- BSM 39.85
- ARWR 83.89
- Support Level
- BSM $11.97
- ARWR $21.61
- Resistance Level
- BSM $12.24
- ARWR $29.34
- Average True Range (ATR)
- BSM 0.19
- ARWR 1.30
- MACD
- BSM 0.01
- ARWR 0.84
- Stochastic Oscillator
- BSM 12.26
- ARWR 97.33
About BSM Black Stone Minerals L.P. Common units representing limited partner interests
Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.